We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$57.2B
AUM Growth
+$4B
Cap. Flow
-$1.18B
Cap. Flow %
-2.06%
Top 10 Hldgs %
12.48%
Holding
3,271
New
835
Increased
795
Reduced
814
Closed
718

Sector Composition

Rank Sector Weight
1 Technology 9.59%
2 Consumer Discretionary 8.82%
3 Industrials 8.12%
4 Financials 7.95%
5 Healthcare 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXS icon
2426
Stereotaxis
STXS
$137M
$143K ﹤0.01%
+54,890
New +$130K
JRVR icon
2427
James River Group Holdings
JRVR
$200M
$142K ﹤0.01%
15,287
-40,294
-72% -$370K
OABI icon
2428
OmniAb
OABI
$499M
$141K ﹤0.01%
+26,069
New +$150K
HTLD icon
2429
Heartland Express
HTLD
$979M
$141K ﹤0.01%
+11,833
New +$150K
NWL icon
2430
Newell Brands
NWL
$2.63B
$141K ﹤0.01%
17,547
-1,249,415
-99% -$9.95M
WGS icon
2431
GeneDx Holdings
WGS
$2.36B
$140K ﹤0.01%
+15,341
New +$92.1K
ABEO icon
2432
Abeona Therapeutics
ABEO
$361M
$138K ﹤0.01%
+19,026
New +$121K
GDYN icon
2433
Grid Dynamics Holdings
GDYN
$644M
$137K ﹤0.01%
+11,137
New +$145K
TASK icon
2434
TaskUs
TASK
$667M
$136K ﹤0.01%
11,710
-49,472
-81% -$618K
APPS icon
2435
Digital Turbine
APPS
$1.53B
$136K ﹤0.01%
51,928
-68,616
-57% -$291K
BCS icon
2436
Barclays
BCS
$94.6B
$135K ﹤0.01%
+14,261
New +$117K
CATX icon
2437
Perspective Therapeutics
CATX
$354M
$133K ﹤0.01%
+11,172
New +$95.3K
LCUT icon
2438
Lifetime Brands
LCUT
$220M
$131K ﹤0.01%
12,464
-4,721
-27% -$41.5K
DH icon
2439
Definitive Healthcare
DH
$68.4M
$128K ﹤0.01%
+15,901
New +$141K
GRAB icon
2440
Grab
GRAB
$15.1B
$127K ﹤0.01%
+40,468
New +$130K
ACHV icon
2441
Achieve Life Sciences
ACHV
$744M
$126K ﹤0.01%
+27,747
New +$123K
SILV
2442
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$126K ﹤0.01%
18,898
-6,015
-24% -$35.2K
SYRS
2443
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$124K ﹤0.01%
+23,106
New +$160K
EU
2444
enCore Energy
EU
$221M
$123K ﹤0.01%
+28,021
New +$119K
CBIO
2445
Crescent Biopharma
CBIO
$618M
$122K ﹤0.01%
+406
New +$121K
OPBK icon
2446
OP Bancorp
OPBK
$235M
$117K ﹤0.01%
11,761
-13,012
-53% -$136K
ALTO icon
2447
Alto Ingredients
ALTO
$326M
$117K ﹤0.01%
+53,734
New +$113K
SMXT icon
2448
Solarmax Technology
SMXT
$20M
$117K ﹤0.01%
+1,062
New +$93.2K
GOSS icon
2449
Gossamer Bio
GOSS
$83.3M
$116K ﹤0.01%
+98,036
New +$108K
SAND
2450
DELISTED
Sandstorm Gold
SAND
$109K ﹤0.01%
+20,722
New +$95.9K

Similar funds

Balyasny Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Balyasny Asset Management held 3,271 positions worth $57.2B, up 7.5% from $53.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Balyasny Asset Management's Q1 2024 filing shows 835 new, 795 increased, 814 reduced and 718 closed positions. Its largest new stake was Public Service Enterprise Group: 2,419,537 shares worth $162M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $650M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Balyasny Asset Management's largest Q1 2024 buy was Public Service Enterprise Group: 2,419,537 shares worth $162M.
  • Balyasny Asset Management added most to Broadcom in Q1 2024, an estimated $342M increase.
  • Balyasny Asset Management's biggest Q1 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $650M.
  • Balyasny Asset Management fully exited Splunk Inc in Q1 2024, selling an estimated $263M.
  • Balyasny Asset Management's ten largest holdings make up 12% of its $57.2B portfolio in Q1 2024.
  • Balyasny Asset Management opened 835 new positions and closed 718 in Q1 2024.
  • Balyasny Asset Management's portfolio value rose 7.5% quarter-over-quarter to $57.2B.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.